drugset / Trial / NCT02432157

Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage:

NCT02432157

Phase 1/2 Unknown 50 enrolled Thomas Jefferson University
RandomizedParallel-groupSingle-blindPrevention

Summary

Subarachnoid hemorrhage (SAH) occurs after rupture of cerebral aneurysms. Treatment of SAH focuses on avoiding medical complications including cerebral vasospasm, which may result in limited circulation to the brain. Cerebral vasospasm, or thinning of the arteries of the brain, is a feared complication that could potentially cause stroke and worst outcomes after SAH. Hypertonic saline (HTS) is a compound that may be used to prevent vasospasm following SAH by enhancing the circulation in the brain. This study will evaluate if a protocol of volume expansion with HTS is safe and effective in patients with subarachnoid hemorrhage for the prevention of cerebral vasospasm.

Timeline

Start
2015-01
Primary completion
2017-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 3 % Intravenous
Subject Hypertonic saline Unknown 250 ml Intravenous